Literature DB >> 11491191

The 15D instrument of health-related quality of life: properties and applications.

H Sintonen1.   

Abstract

The 15D is a generic, comprehensive, 15-dimensional, standardized, self-administered measure of health-related quality of life (HRQoL) that can be used both as a profile and single index score measure. This paper examines the acceptability, reliability, validity, discriminatory power and responsiveness to change of its health state descriptive system and valuation system and presents some examples of applications. As a profile measure on roughly comparable dimensions the 15D performs equally well as the Nottingham Health Profile (NHP) and SF-20, in some respects even better, and clearly better than EQ-5D. The remaining nine to ten dimensions of the 15D provide a large reserve in terms of discriminatory power and responsiveness to change. The valuation system is based on an application of the multiattribute utility theory. The single index score (15D score) on a 0-1 scale, representing the overall HRQoL, is calculated from the health state descriptive system by using a set of population-based preference or utility weights. The 15D scores are shown to be highly reliable, sensitive and responsive to change, generalisable at least in Western-type societies, and particularly valid for deriving quality-adjusted life years (QALYs) gained for resource allocation purposes. The instrument is recommended by the Washington Panel and is available in several languages for clinical economic evaluation and population studies.

Entities:  

Mesh:

Year:  2001        PMID: 11491191     DOI: 10.3109/07853890109002086

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  300 in total

Review 1.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure.

Authors:  Taru Kantola; Suvi Mäklin; Anna-Maria Koivusalo; Pirjo Räsänen; Anne Rissanen; Risto Roine; Harri Sintonen; Krister Höckerstedt; Helena Isoniemi
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

3.  The Scandinavian Solutions for Wellness study - a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disorders.

Authors:  Vibeke Porsdal; Catherine Beal; Ole Kristian Kleivenes; Egil W Martinsen; Eva Lindström; Harriet Nilsson; Pär Svanborg
Journal:  BMC Psychiatry       Date:  2010-06-10       Impact factor: 3.630

4.  Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications.

Authors:  J Hahl; H Hämäläinen; H Sintonen; T Simell; S Arinen; O Simell
Journal:  Qual Life Res       Date:  2002-08       Impact factor: 4.147

5.  Does septoplasty enhance the quality of life in patients?

Authors:  Maija L Hytönen; Markus Lilja; Antti A Mäkitie; Harri Sintonen; Risto P Roine
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-25       Impact factor: 2.503

6.  Psychometric performance of the national eye institute 25-item visual function questionnaire: in Turkish diabetic retinopathy patients.

Authors:  Akinci Fevzi; Yildirim Aysegul
Journal:  Patient       Date:  2008-04-01       Impact factor: 3.883

7.  Diagnostic tools in Rhinology EAACI position paper.

Authors:  Glenis Scadding; Peter Hellings; Isam Alobid; Claus Bachert; Wytske Fokkens; Roy Gerth van Wijk; Philippe Gevaert; Josep Guilemany; Livije Kalogjera; Valerie Lund; Joaquim Mullol; Giovanni Passalacqua; Elina Toskala; Cornelius van Drunen
Journal:  Clin Transl Allergy       Date:  2011-06-10       Impact factor: 5.871

8.  Health-related quality of life as an outcome variable in Parkinson's disease.

Authors:  Pablo Martinez-Martin; Mónica M Kurtis
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

9.  Valuing benefits to inform a clinical trial in pharmacy : do differences in utility measures at baseline affect the effectiveness of the intervention?

Authors:  Michela Tinelli; Mandy Ryan; Christine Bond; Anthony Scott
Journal:  Pharmacoeconomics       Date:  2013-02       Impact factor: 4.981

10.  The "costs" of urinary incontinence for women.

Authors:  Leslee L Subak; Jeanette S Brown; Stephen R Kraus; Linda Brubaker; Feng Lin; Holly E Richter; Catherine S Bradley; Deborah Grady
Journal:  Obstet Gynecol       Date:  2006-04       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.